Skip to main content
OpenTrials
Completed

NCT Number: NCT06123390

Evaluating RISQ System Implementation in Acutely Malnourished Children in Chad (CRIMSON)

The purpose of this study is to evaluate the effect of the Responses to Illness Severity Quantification (RISQ) system implementation on mortality and processes of care in a nutritional program treating children 6 to 59 months of age with acute malnutrition in Ngouri, Chad.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–59 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ngouri

Ngouri, Chad

About this study

The CRIMSON Study is a 12-month cluster randomized trial that will evaluate the effect of implementing the RISQ system compared with usual care on all-cause mortality, in children with acute malnutrition aged 6 to 59 months enrolled in the OptiMA nutrition program in Chad.

The intervention is the RISQ System and the clusters are the individual health centres that are randomized with a ratio of 1:1, RISQ System: Usual care. The 12 month intervention period will begin following a run in phase in which sites randomized to intervention will introduce and establish the new practices and in which sites randomized to usual care will continue to provide usual care.

The RISQ system is a scientifically developed clinical decision support tool that consists of: [1] the RISQ score; [2] documentation form; [3] score-matched recommendations and [4] an implementation package. The RISQ score, developed through our prospective observational study in Maiduguri Nigeria ((NCT04582773) ranges from 0 to 26 (high scores indicating greatest severity of illness). In the development dataset, the mean RISQ score on admission was 3.6 in hospital survivors and 7.3 for children dying <48hr of admission. RISQ scores <24hr before death had Area Under the Receiver Operating Characteristics Curve (AUROC) of 0.93. The RISQ score performed similarly well in children independent of their clinical conditions as a diagnosis-independent measure of severity of illness. Additionally, through a study of 903 hospitalized children with Severe Acute Malnutrition (SAM), the RISQ score could discriminate between points of escalation or de-escalation of care and can reflect illness severity in children throughout hospitalization. The documentation form provides visual representation of the sub-scores of each RISQ score items and guidance for score calculation. The score-matched recommendations of the RISQ system that are linked to the RISQ scores are derived from an expert panel of clinicians, with over 100 years of collective experience caring for acutely malnourished children, and provide guidance about intensity of care. This includes the frequency of observation, consideration of secondary review, inpatient admission, and transfer into / out of inpatient care areas where more intensive treatments are provided.The implementation package consists of theoretical and practical training modules including specific 'train the trainers' sessions for key personal involved in the implementing programs.

The CRIMSON study is nested within the existing framework of the OptiMA nutritional program and observational study conducted by the Alliance for International Medical Action (ALIMA). The program involves health centres within Ngouri, a sub-prefecture of the Lake Region in Chad (and surrounding area) plus an inpatient unit at the Ngouri District Hospital providing care for children with acute malnutrition. Inclusion criteria for the OptiMA program are based on mid-upper arm circumference (MUAC) of <125mm and/or bilateral pitting oedema. Usual care in the OptiMA program is as follows: nutritional treatment to participants consists of Ready-to-use-Therapeutic Food (RUTF) adjusted based on their MUAC value throughout the duration of their care. Management of the children with acute illnesses follows the established approach for management of children with severe acute malnutrition using the World Health Organization (WHO) "danger signs" and Integrated Management of Childhood Illness (IMCI) algorithms to guide admission to hospital. Additionally, as part of the OptiMA program in Ngouri, pulse oximeters have been introduced in all health centres and inpatient care unit, following training by ALIMA. Included in the routine visits of the program is the measurement and documentation of each of the 7 RISQ score items [heart rate, respiratory rate, respiratory effort, oxygen saturation, temperature, level of consciousness and oxygen use (oxygen is currently only available in the inpatient care)] by nurses.

The investigators anticipate that implementation of the RISQ system in a nutrition treatment program will improve sensitivity and specificity of clinical evaluation in determining which children require hospitalization, and what level of medical care within the in-patient unit is appropriate and in turn potentially reduce mortality.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children:

  • age: 6 to 59 months at enrolment on the day of their admission/re-admission to the OptiMA program
  • written consent to participate

Front line staff providing care to patients enrolled in the Optima program:

[1] Registered Nurses [2] Medical Doctors

Exclusion criteria

Children:

  • Children allergic to milk, peanuts and/or ready-to-use therapeutic food (RUTF)
  • Children not residing in one of the study areas.

Treatment and study plan

The Responses to Illness Severity Quantification (RISQ) System

Other

The RISQ System involves: [1] the RISQ score: calculated routinely using the [2] documentation record and linked to [3] score-matched recommendations. Introduction into clinical care is supported by [4] the RISQ System implementation package. During the 2 month prior to implementation, front-line staff in the intervention arm will be trained on and will practice the use of the RISQ System .

Primary outcomes

  1. All-cause mortality.

    Time frame: 12 months

    Mortality over the period beginning at admission to the program and ending at either program discharge or to a maximum of 60 days after study enrolment. Program discharge will be one of: [1] medical/anthropometric criteria or [2] defaulting from the program.

    Defaulting from the program is defined as children who do not attend the weekly clinic visits for 3 consecutive weeks.

Secondary outcomes

  1. Timing of inpatient mortality

    Time frame: Duration of hospitalization in days up to 60 days

    Timing will be defined as [a] within 48 hours of hospital admission and [b] timing of death after admission to hospital

  2. Timing of outpatient mortality

    Time frame: Duration of program inclusion in days up to 60 days

    Timing will be defined as [a] within 48 hours of being seen by health-care team [b] timing of death after being seen by outpatient health-care team

  3. Therapeutic intensity

    Time frame: First 24 hours from admission to hospital

    To be measured by location on admission to inpatient care (Intensive Care Unit/Phase1/Phase2)

  4. Efficiency of inpatient care

    Time frame: Duration of hospitalization in days up to 60 days

    Efficiency measured by length of inpatient stay (whole or part days)

  5. Workload

    Time frame: Month 1 and month 12

    Frontline staff perception of workload measured through questionnaires using a 5 point scale

  6. Knowledge

    Time frame: Month 1 and month 12

    Frontline staff knowledge of assessment skills measured through questionnaire using a 5 point scale

  7. Fidelity of RISQ Implementation

    Time frame: 12 months

    Number of measured vital signs performed on individual patient at health centre visit with corresponding disposition in program, recorded in 10 randomly selected patients/week/health centre

  8. Acceptability

    Time frame: Month 1 and month 12

    Acceptability of the RISQ System by front-line staff evaluated through a questionnaire using a 5 point scale

Other outcomes

  1. Lived experience of RISQ System implementation

    Time frame: one time at end of 12 month implementation period

    Lived experiences measured by open ended questions about strengths/weaknesses of RISQ System implementation added to frontline staff perception questionnaire at end of intervention period

  2. comparison of automated versus manual measurements of vital signs (Respiratory rate in breaths/min)

    Time frame: During run-in phase prior to implementation of intervention, on average 2 months

    Comparison determined by agreement between the two different methods for respiratory rate measurement

  3. comparison of automated versus manual measurements of vital signs (Temperature in degrees Celsius)

    Time frame: During run-in phase prior to implementation of intervention, on average 2 months

    Comparison determined by agreement between the two different methods for temperature measurement

  4. Comparison of RISQ scores among children with different clinical conditions in inpatient care

    Time frame: Duration of hospitalization in days up to 60 days

    Differences in RISQ scores among children with different clinical diagnoses a) on admission to inpatient care; b) throughout inpatient care; and c) at exit from inpatient care

Sponsors and collaborators

Lead sponsor

The Hospital for Sick Children

Other

Collaborators

  • Alliance for International Medical Action

Registry information

Official study title

Cluster-Randomized Trial of the Implementation of the Responses to Illness Severity Quantification System (RISQ) in Children With Acute Malnutrition Six to Fifty-nine Months of Age in Ngouri, Chad

Acronym: CRIMSON

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Nov 8, 2023
Registry last updated
Jun 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.